Differential Effects of a Mitogen-Activated Protein Kinase Kinase Inhibitor on Human Neutrophil Responses to Chemotactic Factors
- 1 March 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 232 (2) , 474-477
- https://doi.org/10.1006/bbrc.1997.6296
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Activation of MEKK by Formyl-methionyl-leucyl-phenylalanine in Human NeutrophilsPublished by Elsevier ,1996
- Chemotactic Peptide-induced Activation of MEK-2, the Predominant Isoform in Human NeutrophilsJournal of Biological Chemistry, 1996
- 5-Oxo-eicosanoids and Hematopoietic Cytokines Cooperate in Stimulating Neutrophil Function and the Mitogen-activated Protein Kinase PathwayJournal of Biological Chemistry, 1996
- Mitogen-activated Protein Kinase in Neutrophils and Enucleate Neutrophil CytoplastsJournal of Biological Chemistry, 1996
- Interleukin-8 Regulation of the Ras/Raf/Mitogen-activated Protein Kinase Pathway in Human NeutrophilsJournal of Biological Chemistry, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- How MAP Kinases Are RegulatedJournal of Biological Chemistry, 1995
- FMLP activates Ras and Raf in human neutrophils. Potential role in activation of MAP kinase.Journal of Clinical Investigation, 1994
- Signal transduction via the MAP kinases: proceed at your own RSK.Proceedings of the National Academy of Sciences, 1993
- Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies.Cell Regulation, 1991